CVS (CVS) reported fourth quarter and full-year 2024 earnings Wednesday, beating Wall Street's expectations and sending its stock up 15% for the day. Full-year revenue came in at $372.8 billion, while ...

RBC Capital analyst Ben Hendrix raised the firm’s price target on CVS Health (CVS) to $74 from $58 and keeps an Outperform rating on the ...

Deutsche Bank raised the firm’s price target on CVS Health (CVS) to $70 from $66 and keeps a Buy rating on the shares. The company issued a ...

Q4 2024 Earnings Call Transcript February 12, 2025 CVS Health Corporation beats earnings expectations. Reported EPS is $1.19, expectations were $0.914. Operator: Good morning and thank you all for ...

The margin of that beat was the widest since the second quarter of 2020. This is breaking news. Check back for updates. This content was created by MarketWatch, which is operat & Co. MarketWatch is ...

What's more, the pharmacy giant isn't immune to competition: Amazon Pharmacy is expanding. That's something CVS will have to ...

We recently compiled a list of the Jim Cramer Recently Talked About These 11 S&P 500 Stocks. In this article, we are going to ...

This article was subjected to a comprehensive fact-checking process. Our professional fact-checkers verify article information against primary sources, reputable publishers, and experts in the field.